Avalyn Pharma (AVLN) vs MannKind (MNKD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avalyn Pharma is the larger company by market cap ($1.14 billion vs $1.10 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVLN | MNKD |
|---|---|---|
| Share price | $25.72 | $3.42 |
| Market cap | $1.14B | $1.10B |
| 1-day change | +0.74% | -0.87% |
| YTD return | — | -39.15% |
| 1-year return | — | -38.94% |
| 5-year return | — | -32.22% |
| Forward P/E | — | 26.82 |
| EPS (TTM) | $-2.47 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.17 | $6.51 |
| 52-week low | $24.15 | $2.23 |
| Distance from 52-week high | -35.97% | -47.47% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +140.28% | +129.24% |
| Average volume | 234.81K | 4.48M |
| Shares outstanding | 44.33M | 321.54M |
| Employees | 55 | 591 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Avalyn Pharma
AVLN stock →Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 55 employees
About MannKind
MNKD stock →MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address various unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Health Care · Biotechnology: Pharmaceutical Preparations · 591 employees
AVLN vs MNKD FAQ
Which is bigger, Avalyn Pharma or MannKind?
Avalyn Pharma (AVLN) is larger, with a market capitalization of $1.14B compared with $1.10B for MannKind (MNKD).
Are Avalyn Pharma and MannKind in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.